Everyone knows Ozempic and Wegovy make you eat less — but how? The answer is more elegant than “it kills your appetite,” and understanding it explains almost everything about these drugs: why they work, why they cause nausea, why they are injected weekly, and why the newer versions hit harder. GLP-1 is a hormone your own gut already makes. The drugs just borrow it and make it last.
What GLP-1 Actually Is
GLP-1 stands for glucagon-like peptide-1. It is an incretin — a hormone your small intestine releases within minutes of eating. Its natural job is to coordinate your body’s response to a meal: tell the pancreas to release insulin, tell the brain you are full, and slow the stomach so everything is processed in order. In other words, GLP-1 is the body’s own “you have eaten enough” signal. Drugs like semaglutide are GLP-1 receptor agonists — molecules shaped closely enough to GLP-1 to switch on the same receptors.
That single fact reframes the whole category. These are not foreign stimulants forcing your body to do something unnatural; they amplify a signal you already produce every time you eat. Everything below follows from that.
The Three Places It Acts
1. The brain. GLP-1 receptors in the hypothalamus — the brain’s appetite control centre — register the signal and turn down hunger. This is the effect people feel most directly: food is simply less interesting, cravings quiet down, and you feel satisfied with far less. It is not willpower being forced; it is the hunger dial being turned down at the source.
2. The stomach. GLP-1 slows gastric emptying, meaning food lingers in your stomach longer. That stretches out the physical sensation of fullness after a meal, so you stay full for hours instead of feeling hungry again quickly. This mechanism is doing a lot of the heavy lifting on appetite — and, as we will see, it is also the source of the side effects.
3. The pancreas. GLP-1 tells the pancreas to release insulin when blood sugar is high, and to ease off glucagon (a hormone that raises blood sugar). Crucially this is glucose-dependent — it only pushes insulin when sugar is actually elevated, which is why GLP-1 drugs rarely cause dangerous low blood sugar on their own. This is the mechanism that made them diabetes drugs first and weight-loss drugs second.
The same slowed stomach that keeps you full for hours is also what causes the nausea. The main benefit and the main side effect are the same mechanism wearing two hats.Why GLP-1 side effects are inseparable from the results
Why It Causes Weight Loss — and Nausea
Stack the three effects together and the weight loss is almost arithmetic: you want less food (brain), you fill up faster and stay full longer (stomach), and your blood sugar and insulin response are steadier (pancreas). People eat substantially less without the white-knuckle hunger that sinks ordinary diets. In the landmark STEP-1 trial, semaglutide produced around 15% mean body-weight reduction over 68 weeks — a figure diet and exercise alone rarely approach.
The flip side comes from that slowed stomach. When digestion is deliberately delayed, the common results are nausea, early fullness, and bowel changes — the most frequent side effects of every GLP-1 drug. They tend to be worst early and ease as the body adapts, which is exactly why doses are raised gradually rather than started high. Our Ozempic side effects guide covers this in depth, and the lean-mass question in Ozempic and muscle loss.
Natural Hormone vs the Drug
If your body already makes GLP-1, why inject it? Because natural GLP-1 is destroyed almost immediately — an enzyme called DPP-4 breaks it down within minutes. That is fine for a hormone meant to manage a single meal, but useless as a treatment. The breakthrough behind these drugs was re-engineering the GLP-1 molecule to resist that breakdown, so a single injection keeps signalling for days. That is the entire reason semaglutide is a once-weekly shot rather than something you would need constantly.
| Feature | Natural GLP-1 | GLP-1 drug (e.g. semaglutide) |
|---|---|---|
| Source | Released by your gut after eating | Injected, engineered analog |
| Lifespan | Minutes (broken down by DPP-4) | Days (resists breakdown) |
| Effect | Manages one meal | Sustained appetite and glucose control |
| Dosing | Continuous, automatic | Once weekly |
Why Newer Drugs Hit Harder
GLP-1 is just the first lever. The newest drugs add more receptors to pull at once. Tirzepatide (Mounjaro, Zepbound) adds GIP, a second incretin, making it a dual agonist — and it outperformed semaglutide head-to-head. Retatrutide goes further still, adding glucagon receptor activity (which raises energy expenditure and targets liver fat) for a triple agonist that produced the largest trial weight loss yet. Same core GLP-1 idea, more pathways layered on.
That is the throughline of the entire class: GLP-1 is the foundation, and each newer drug stacks additional hormone signals on top. We map the whole family in the GLP-1 weight-loss drugs guide, and compare the heavy hitters in retatrutide vs tirzepatide and tirzepatide vs semaglutide.
Explore the full GLP-1 class and the research behind each compound in the TrueLabs library.
FAQ
Tap a question to reveal the answer.
How do GLP-1 drugs work?
They mimic GLP-1, a natural gut hormone released after eating, by switching on the same receptors. This produces three coordinated effects: reduced appetite in the brain, slower stomach emptying so you stay full longer, and better blood-sugar control via the pancreas. Together those drive the appetite reduction and weight loss the drugs are known for.
Why do GLP-1 drugs cause weight loss?
Because all three of their effects push in the same direction. You want less food, you fill up faster and stay full longer, and your insulin and blood sugar are steadier. The result is eating substantially less without the intense hunger that usually derails dieting, which in trials translated into around 15% body-weight loss for semaglutide.
Why does Ozempic make you nauseous?
Nausea comes from the same mechanism that helps you lose weight: slowed gastric emptying. Delaying digestion keeps you full but also commonly causes nausea, early fullness, and bowel changes, especially early on. This is why doses are increased gradually, giving the body time to adapt as the effects usually ease.
Is GLP-1 a natural hormone?
Yes. GLP-1 (glucagon-like peptide-1) is an incretin hormone your small intestine releases within minutes of eating. The drugs are not foreign stimulants; they are engineered copies of this hormone designed to activate the same receptors, amplifying a signal your body already produces at every meal.
Why are GLP-1 drugs injected weekly?
Natural GLP-1 is broken down by an enzyme called DPP-4 within minutes, which is useless for treatment. The drugs are re-engineered to resist that breakdown, so a single injection keeps signalling for days. That extended lifespan is exactly what allows once-weekly dosing instead of constant administration.
Do GLP-1 drugs cause low blood sugar?
On their own, rarely. GLP-1 stimulates insulin in a glucose-dependent way, meaning it only pushes insulin when blood sugar is actually elevated. The main hypoglycemia risk comes when they are combined with other glucose-lowering drugs like insulin or sulfonylureas, not from the GLP-1 drug by itself.
What is the difference between GLP-1, GIP, and glucagon drugs?
They are different hormone receptors the newer drugs target. Semaglutide is GLP-1 only. Tirzepatide adds GIP, a second incretin, as a dual agonist. Retatrutide adds glucagon as well, making it a triple agonist. Each added receptor tends to increase weight loss, which is why the newest multi-receptor drugs hit hardest.
Related reading
- GLP-1 weight-loss drugs guide
- Ozempic side effects
- Ozempic and muscle loss
- Retatrutide vs tirzepatide
- Ozempic vs Wegovy
References
- Wilding JPH, et al. Once-weekly semaglutide in obesity, STEP-1. New England Journal of Medicine, 2021.
- Drucker DJ. Mechanisms of action of GLP-1 receptor agonists (incretin physiology). Cell Metabolism / review literature.
- Nauck MA, et al. GLP-1 receptor agonists: gastric emptying, appetite, and insulin secretion.
This article is informational and summarizes published research. It is not medical advice, a treatment protocol, or dosing guidance. Prescription medications should be used only under a licensed clinician, and any research compounds referenced are for laboratory use only. Always consult the current scientific literature and comply with local regulations.